Kaplan-Meier curves. (A-B) OS and PFS by prior checkpoint inhibition at haplo-SCT. Two-year OS was 77% in the CPI cohort vs 71% in the no-CPI cohort (P = .599); 2-year PFS: 78% vs 53%, respectively (P = .066). (C-D) OS and PFS by disease status at time of haplo-SCT (CR, PR, SD/PD). Two-year OS was 81% in CR patients, 75% in PR patients, and 20% in patients in SD/PD (P < .001); 2-year PFS was 70% vs 63% vs 20% (P < .001), respectively.